Literature DB >> 12211193

Severe cold hemagglutinin disease (CHD) successfully treated with rituximab.

Monika Engelhardt, Andreas Jakob, Björn Ruter, Martin Trepel, Friedrich Hirsch, Michael Lübbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12211193     DOI： 10.1182/blood-2002-04-1213

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin disease.

Authors:  A Vassou; V Alymara; A Chaidos; K L Bourantas
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

Review 2.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 3.  Rituximab in the treatment of autoimmune haemolytic anaemia.

Authors:  Chaturaka Rodrigo; Senaka Rajapakse; Lallindra Gooneratne
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.